Patient-derived organoids after neoadjuvant FOLFIRINOX predict therapy resistance in pancreatic ductal adenocarcinoma
Ontology highlight
ABSTRACT: Patient-derived organoids after neoadjuvant FOLFIRINOX predict therapy resistance in pancreatic ductal adenocarcinoma
PROVIDER: PRJNA716264 | ENA |
REPOSITORIES: ENA
ACCESS DATA